Largest-ever study IDs risk factors, paves way for interventions to help
June 28, 2018
| By Susan Keown / Fred Hutch News Service
Being the caregiver of a loved one with a serious illness can be a tough job — and one that's too often under the radar. In a new study, Fred Hutch researchers take a hard look at how some of these "silent supporters" are doing.
‘Incredibly big change’ in treatment of deadly skin cancer, new data show
June 4, 2018
| by Susan Keown / Fred Hutch News Service
Immunotherapy drugs have transformed the treatment of a deadly skin cancer, Merkel cell carcinoma. New trial results show these drugs help many patients survive much longer than would otherwise be possible.
Seattle native works to support lifesaving research — like the immunotherapy that put his cancer in remission
May 3, 2018
| By Sabrina Richards / Fred Hutch News Service
Throughout the 2018 Major League Baseball season, Fred Hutch and the Seattle Mariners are recognizing “Hutch Heroes,” including lymphoma survivor Colin Craig, who works to support our lifesaving research.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.